Pancreatic carcinoma and fast MR imaging: technical considerations for signal intensity difference measurements
Autor: | Veli-Pekka Poutanen, Anneli Piironen, Pekka Laippala, Leena Kivisaari, Riku Kivisaari |
---|---|
Rok vydání: | 2001 |
Předmět: |
Adult
Male medicine.medical_specialty Pancreatic disease Gadolinium chemistry.chemical_element Lesion Carcinoma Medicine Humans Radiology Nuclear Medicine and imaging Prospective Studies Aged medicine.diagnostic_test business.industry Pancreas neoplasm Cancer Magnetic resonance imaging General Medicine Middle Aged medicine.disease Magnetic Resonance Imaging Pancreatic Neoplasms medicine.anatomical_structure chemistry Female Radiology medicine.symptom business Pancreas Nuclear medicine |
Zdroj: | European journal of radiology. 38(2) |
ISSN: | 0720-048X |
Popis: | The aim of the study was to find the fast magnetic resonance imaging (MRI) sequence with the best conspicuity of pancreatic lesions at 1.0 T and 1.5 T. A total of 51 patients were studied. At 1.0 T, 22 patients with verified malignant pancreatic lesions were studied using the T1-weighted breath-hold spoiled Gradient Echo 2D FLASH(75) or FLASH(80) sequences, both non-enhanced and enhanced with gadolinium. The relative signal intensity difference (SIDR) between lesion and pancreas was measured. At 1.5 T, 20 patients with primary malignant lesions of the pancreas, and nine patients with 13 benign cystic lesions were examined with the breath-hold T2-weighted TrueFISP, HASTE, T1-weighted 2D FLASH(80) and FLASH(50) fat saturation sequences, the latter also enhanced. The signal intensity (SI) values of the pancreas and lesions as well as the pancreatic standard deviation (S.D.) were assessed, and the contrast-to-noise ratio (C/N) was determined. Statistical significances were calculated using an analysis of variance. No statistically significant difference between the sequences used in the conspicuity of cancer was found, either at 1.0 T or at 1.5 T. At 1.5 T, the T2-weighted TrueFISP and HASTE sequences could differentiate benign, cystic lesions from malignant lesions. |
Databáze: | OpenAIRE |
Externí odkaz: |